Skip to main content
Skip to main content
NXGT logo

Nexteligent Holdings, Inc. (NXGT)

$0.01 +$0.00 (+0.60%) |CouncilSTRONG SELL · 0 · F
Bottom line: STRONG SELL — our Council read (0/100) and AI Score (0/100) broadly agree.
MCap: 249K| Vol: 5.0K| 52-wk range: $0.01 – $0.01
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Nexteligent Holdings, Inc. (NXGT) trades at $0.01. Nexteligent Holdings, Inc. aggregates healthcare professional services and technology, focusing on telemedicine solutions and financial administration. Market cap: $249,282, Sector: Healthcare.

Price live · AI analysis from Jun 15, 2026
Nexteligent Holdings, Inc. aggregates healthcare professional services and technology, focusing on telemedicine solutions and financial administration. The company provides virtual healthcare programs and end-to-end revenue cycle management, including denied claims recovery, for diverse healthcare institutions.

Analyst Coverage for NXGT: NXGT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NXGT against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
STRONG SELL 0/100 · F

NXGT: 1/1 perspectives are bearish.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Nexteligent Holdings, Inc. (NXGT) Healthcare & Pipeline Overview

CEOPaul Cristiano
Employees9
HeadquartersAvon, US
IPO Year1999

Nexteligent Holdings, Inc. aggregates healthcare professional services and technology, specializing in telemedicine solutions for virtual care management and financial services like revenue cycle management and denied claims recovery. The company serves eldercare, municipal, and non-profit organizations, alongside hospitals and physician groups, aiming to enhance operational efficiency and patient care quality through technology-driven healthcare administration.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 15, 2026

What Is the Investment Thesis for NXGT?

Nexteligent Holdings, Inc. operates in critical and growing segments of the healthcare industry, specifically telemedicine and revenue cycle management, which are driven by the ongoing need for cost containment, efficiency improvements, and enhanced patient outcomes. The company's dual focus on technology-driven virtual care and specialized financial administration provides a comprehensive value proposition to its diverse client base, including eldercare facilities, hospitals, and physician groups. The market demand for telemedicine is expanding rapidly, fueled by technological advancements and shifting patient preferences, while effective revenue cycle management remains paramount for healthcare providers to navigate complex billing and claims processes, particularly in recovering denied claims. Nexteligent's offering of ready-to-deploy preventative care solutions, such as chronic condition management and remote patient telemonitoring, aligns with broader healthcare trends emphasizing proactive health and value-based care. However, the company's current negative profit margin of -39.3% indicates significant operational challenges or early-stage investment, and its OTC Other listing suggests limited market visibility and liquidity, posing potential risks for investors. Future growth will depend on successful contract acquisition and scaling of its service offerings to achieve profitability.

Based on FMP financials and quantitative analysis

NXGT Key Highlights

  • Sector Focus: Operates within the Healthcare sector, specifically in Medical - Care Facilities, addressing critical administrative and patient care needs.
  • Market Cap: Current market capitalization is $0.00 billion, reflecting its status as a micro-cap or non-reporting entity.
  • Profitability: Reports a profit margin of -39.3%, indicating the company is currently operating at a loss.
  • Employee Base: Maintains a lean operational structure with 9 employees, suggesting a highly specialized or early-stage business model.
  • Service Breadth: Offers a comprehensive suite of services spanning telemedicine solutions, end-to-end revenue cycle management, and ready-to-deploy preventative care programs.

Who Are NXGT's Competitors?

NXGT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
HWAIF Healwell AI Inc. $0.53 -3.52% $160.75M 65
ASSF Assisted 4 Living, Inc. $1.00 +0.00% $45.35M 63
FTRP Field Trip Health Ltd. $0.84 +1.07% $9.81M 62
SLHGP Skylight Health Group Inc. $12.00 -5.88% 61
NWKHY Netcare Limited $7.17 +0.00% $843.64M 50
AONC American Oncology Network, Inc. $10.00 +0.00% $292.48M 50
DCGO DocGo Inc. $0.59 +5.81% $58.07M 51
JYNT The Joint Corp. $9.16 +2.10% $130.55M 51

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are NXGT's Key Strengths?

  • Comprehensive suite of integrated healthcare professional services and technology solutions.
  • Specialization in critical areas like telemedicine and denied claims recovery.
  • Ready-to-deploy preventative care programs addressing current healthcare trends.
  • Targeted focus on eldercare, municipal, and non-profit sectors.

What Are NXGT's Weaknesses?

  • Negative profit margin (-39.3%) indicates current unprofitability.
  • Small employee base (9 employees) may limit scalability and operational capacity.
  • OTC Other listing results in limited market visibility and liquidity.
  • "Unknown" disclosure status suggests potential lack of transparent financial reporting.

What Could Drive NXGT Stock Higher?

  • Securing significant new contracts for telemedicine solutions with large healthcare systems or government entities, demonstrating scalability.
  • Announcing successful implementation and measurable cost savings or efficiency gains for clients through its revenue cycle management services.
  • Expansion of its preventative care solutions into new markets or through partnerships, increasing adoption rates for chronic condition management or remote patient monitoring.
  • Any future public disclosure of financial performance or operational milestones that could improve market visibility and investor confidence.
  • Successful recovery of a substantial volume of previously denied claims for clients, enhancing its reputation and attracting new RCM business.

What Are the Key Risks for NXGT?

  • Financial-distress signal — its Altman Z-Score of -20.67 sits in the distress zone (elevated bankruptcy risk).
  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • Persistent negative profit margin (-39.3%) indicates a lack of profitability, raising concerns about long-term financial viability without significant operational improvements.
  • Limited market visibility and liquidity due to its OTC Other listing, which can hinder investor interest and make share trading challenging.
  • Intense competition within the healthcare services and technology sector, potentially limiting market share growth and pricing power.
  • "Unknown" disclosure status creates significant information asymmetry for investors, making it difficult to assess financial health and strategic direction.
  • Dependence on regulatory changes in telemedicine and healthcare reimbursement policies, which could impact the demand and profitability of its services.

What Are the Growth Opportunities for NXGT?

  • Expansion of Telemedicine Solutions: The global telemedicine market is projected to continue its robust growth trajectory, driven by increasing demand for remote care, convenience, and cost-efficiency. Nexteligent Holdings, Inc. has a significant opportunity to expand its Telemedicine Solutions arm by securing new contracts with healthcare institutions, especially those in underserved or rural areas, and by integrating advanced AI-driven diagnostic tools. By enhancing its virtual healthcare platforms and broadening its service offerings to include specialized teleconsultations or remote monitoring for a wider range of chronic conditions, Nexteligent can tap into a market that values accessibility and reduced overhead for providers. This could involve strategic partnerships or targeted marketing to municipal and non-profit organizations seeking to modernize their healthcare delivery.
  • Scaling Revenue Cycle Management (RCM) Services: The complexity of healthcare billing and the high rate of denied claims present an ongoing challenge for providers, making efficient RCM services crucial. Nexteligent's specialization in end-to-end revenue cycle management and denied claims recovery offers a substantial growth avenue. The company can expand its market share by demonstrating a strong track record of successful claim recovery and improved financial outcomes for clients. This could involve developing more sophisticated analytics for predictive denial management, expanding its sales force to target more hospital systems and large physician groups, or acquiring smaller RCM firms to consolidate market presence. The demand for outsourced RCM services is expected to grow as healthcare organizations seek to streamline operations and focus on patient care.
  • Penetration of Preventative Care Market: The shift towards value-based care models and preventative health initiatives represents a significant long-term growth opportunity. Nexteligent's ready-to-deploy solutions for chronic condition management, annual wellness visits, transitional care management, behavioral health support, and remote patient telemonitoring are well-aligned with this trend. By actively marketing these comprehensive preventative care programs, the company can establish itself as a key partner for providers aiming to improve patient health outcomes and reduce episodic care costs. This could involve developing subscription-based models for these services or forming alliances with accountable care organizations (ACOs) and health plans to integrate its offerings into broader population health management strategies.
  • Targeting Underserved Healthcare Segments: Nexteligent's stated focus on facilities serving the eldercare sector, municipal bodies, and various not-for-profit organizations represents a strategic niche. These segments often have unique budgetary constraints and specific patient needs that may not be fully addressed by larger, more generalized healthcare service providers. By tailoring its telemedicine and financial administration solutions to the specific requirements of these groups, Nexteligent can build strong, long-term client relationships and establish a reputation as a specialized, reliable partner. This could involve developing customized pricing models, offering specialized training for staff in these facilities, or creating bespoke technology integrations that cater to their unique operational workflows and regulatory environments.
  • Strategic Acquisitions and Partnerships: As an aggregator of healthcare professional services and technology enterprises, Nexteligent has an inherent growth strategy through inorganic means. Identifying and acquiring smaller, innovative technology firms or specialized service providers in areas like AI-driven diagnostics, patient engagement platforms, or niche RCM solutions could significantly expand its capabilities and market reach. Similarly, forming strategic partnerships with larger healthcare systems, technology vendors, or even insurance providers could open new distribution channels and integrate Nexteligent's services into broader healthcare ecosystems. This approach would allow the company to quickly enhance its service portfolio, gain access to new client bases, and leverage complementary expertise to accelerate growth.

What Opportunities Does NXGT Have?

  • Growing demand for telemedicine and virtual care solutions.
  • Increasing need for efficient revenue cycle management and denied claims recovery in a complex healthcare landscape.
  • Expansion into the preventative care market driven by value-based care initiatives.
  • Potential for strategic partnerships or acquisitions to expand service offerings and market reach.

What Threats Does NXGT Face?

  • Intense competition from established healthcare IT firms and specialized RCM providers.
  • Regulatory changes in healthcare and telemedicine could impact operations and compliance requirements.
  • Economic downturns or changes in healthcare reimbursement policies affecting client budgets.
  • High volatility and limited investor interest typically associated with OTC-listed companies.

What Are NXGT's Competitive Advantages?

  • Comprehensive Service Aggregation: Offers a broad, integrated suite of telemedicine, RCM, and preventative care solutions, potentially reducing the need for clients to manage multiple vendors.
  • Specialized Denied Claims Recovery: Expertise in a complex and critical area of RCM, which can significantly impact client profitability and cash flow.
  • Ready-to-Deploy Preventative Care: Provides pre-packaged solutions for high-demand preventative services, offering ease of implementation for healthcare providers.
  • Niche Market Focus: Strategic targeting of eldercare, municipal, and non-profit organizations allows for tailored solutions and deeper client relationships in specific segments.

What Does NXGT Do?

Nexteligent Holdings, Inc. operates as a strategic aggregator within the healthcare sector, consolidating professional services and technology enterprises to deliver comprehensive solutions. The company's core offerings are bifurcated into Telemedicine Solutions and Financial Services. Its Telemedicine Solutions arm is dedicated to the development and management of virtual healthcare initiatives, leveraging technology to create programs that are specifically engineered to reduce operational costs, improve efficiency, and elevate the overall quality of patient interactions. These services are critical for a diverse set of healthcare institutions, including facilities focused on eldercare, as well as municipal bodies and various not-for-profit organizations that require advanced, cost-effective healthcare delivery mechanisms. Beyond virtual care, Nexteligent Holdings, Inc. extends its expertise through its Financial Services segment. This division provides comprehensive, end-to-end revenue cycle management (RCM) solutions, a vital component for the financial health of any healthcare provider. A key specialization within this segment is the recovery of denied claims, a complex and often resource-intensive process that can significantly impact a provider's profitability. The clientele for these financial services is broad, encompassing large hospital systems, independent physician groups, specialized clinics, and long-term care providers. Furthermore, the Financial Services division proactively addresses preventative care by offering complete, ready-to-deploy solutions. These include critical services such as chronic condition management, which helps patients manage long-term health issues; annual wellness visits, designed to promote proactive health maintenance; transitional care management, which supports patients moving between different care settings; behavioral health support, addressing mental health needs; and remote patient telemonitoring, enabling continuous oversight of patient health from a distance. Headquartered in Avon, Connecticut, Nexteligent Holdings, Inc. positions itself as a crucial partner in modernizing healthcare administration and delivery.

What Products and Services Does NXGT Offer?

  • Aggregates healthcare professional services and technology enterprises.
  • Develops and manages virtual healthcare and technological initiatives through Telemedicine Solutions.
  • Provides comprehensive, end-to-end revenue cycle management services.
  • Specializes in the recovery of denied medical claims for healthcare providers.
  • Offers complete, ready-to-deploy solutions for preventative care programs.
  • Manages services like chronic condition management, annual wellness visits, and transitional care management.
  • Supports behavioral health and remote patient telemonitoring services.
  • Aims to curb expenses, enhance operational efficiency, and elevate patient interaction quality for healthcare institutions.

How Does NXGT Make Money?

  • Generates revenue by providing telemedicine development and management services to healthcare institutions.
  • Earns fees through comprehensive revenue cycle management services, including billing, coding, and claims processing.
  • Monetizes its expertise in recovering denied claims, likely through a percentage of recovered funds or fixed fees.
  • Offers ready-to-deploy preventative care solutions, potentially on a subscription or per-service basis.
  • Aggregates various healthcare professional services and technology, implying a platform or integrated service offering model.

What Industry Does NXGT Operate In?

Nexteligent Holdings, Inc. is positioned within the dynamic and evolving healthcare industry, specifically targeting the Medical - Care Facilities segment with its technology and service aggregation model. The broader healthcare sector is undergoing significant transformation, driven by pressures to control costs, improve patient access, and enhance efficiency through digital innovation. Telemedicine, a core offering, is experiencing substantial growth, accelerated by technological advancements and increased adoption rates across various care settings, particularly post-pandemic. The global telemedicine market size was valued at approximately $83.5 billion in 2022 and is projected to grow significantly, indicating a robust market opportunity. Simultaneously, healthcare providers face persistent challenges in financial administration, making efficient revenue cycle management (RCM) services, including denied claims recovery, indispensable. The RCM market is also expanding, driven by increasing regulatory complexities and the need for optimized cash flow. Nexteligent's focus on comprehensive, end-to-end solutions for diverse clients, from eldercare to hospital systems, positions it to capitalize on these trends, albeit within a highly competitive landscape populated by both specialized RCM firms and larger healthcare IT providers.

Who Are NXGT's Key Customers?

  • Facilities serving the eldercare sector.
  • Municipal bodies requiring healthcare administration and technology solutions.
  • Various not-for-profit organizations in the healthcare space.
  • Hospital systems seeking revenue cycle management and virtual care solutions.
  • Physician groups and clinics needing financial administration support.
  • Long-term care providers utilizing RCM and preventative care services.
AI Confidence: 57% Updated: Jun 15, 2026

How Nexteligent Holdings, Inc. Is Valued

Nexteligent Holdings, Inc. carries a market capitalization of 249K, placing it in the micro-cap category.

Company Profile

Nexteligent Holdings, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Avon, US. The company is led by CEO Paul Cristiano. NXGT has traded publicly since 1999.

ROE 3%Key Financial Metrics

Return on equity for Nexteligent Holdings, Inc. stands at 3.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -20.3%, showing how much profit it generates from its asset base. Its free cash flow yield is -26.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.02 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -10.1%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 2/9Financial Health

Nexteligent Holdings, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -20.67 places it in the distress zone, a signal of elevated financial risk.

NXGT Financials

Fundamental Snapshot

Revenue Growth (FY)
+19.1%
Net Income Growth (FY)
+63.9%
EPS Growth (FY)
+135.0%
Free Cash Flow Growth (FY)
+71.1%
Return on Equity (TTM)
+3.2%
Current Ratio
0.0

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Comprehensive suite of integrated healthcare professional services and technology solutions.
  • Specialization in critical areas like telemedicine and denied claims recovery.
  • Ready-to-deploy preventative care programs addressing current healthcare trends.
  • Targeted focus on eldercare, municipal, and non-profit sectors.

Bear Case

  • Negative profit margin (-39.3%) indicates current unprofitability.
  • Small employee base (9 employees) may limit scalability and operational capacity.
  • OTC Other listing results in limited market visibility and liquidity.
  • "Unknown" disclosure status suggests potential lack of transparent financial reporting.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

NXGT Latest News

No recent news available for NXGT.

NXGT Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NXGT.

Price Targets

Wall Street price target analysis for NXGT.

NXGT MoonshotScore

0/100

What does this score mean?

The MoonshotScore rates NXGT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Paul Cristiano

Unknown

Unknown. Information regarding Paul Cristiano's specific career history, educational background, previous leadership roles, or professional credentials prior to his current position at Nexteligent Holdings, Inc. is not provided in the available source data.

Track Record: Unknown. Details on key achievements, strategic decisions, or significant company milestones directly attributable to Paul Cristiano's leadership at Nexteligent Holdings, Inc. are not available in the provided information. The company's current operational status and financial metrics are noted, but specific contributions by the CEO are not detailed.

NXGT OTC Market Information

Nexteligent Holdings, Inc. is classified as "OTC Other," which represents the lowest tier of the OTC Markets Group's three marketplaces (OTCQX, OTCQB, and OTC Pink). Companies listed on OTC Other typically have limited or no public disclosure, meaning they do not meet the minimum financial or disclosure standards required for OTCQX or OTCQB. Unlike companies on major exchanges like NYSE or NASDAQ, which have stringent listing requirements for financial health, corporate governance, and regular reporting, OTC Other companies face minimal regulatory oversight. This tier is often associated with companies that are not current in their reporting or are in financial distress, making it a speculative segment of the market.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Trading on the OTC Other tier typically implies very limited market visibility and liquidity. This means that the volume of shares traded daily is likely low, and the bid-ask spread (the difference between the highest price a buyer is willing to pay and the lowest price a seller is willing to accept) can be wide. Investors may find it difficult to buy or sell shares quickly without significantly impacting the stock price. The "limited market visibility and liquidity" noted in the AI insight confirms that investors should anticipate challenges in executing trades efficiently.
OTC Risk Factors:
  • Limited market visibility and liquidity, making it difficult to buy or sell shares.
  • Increased stock price volatility compared to companies on major exchanges.
  • Lack of comprehensive and timely financial disclosure ("Unknown" status).
  • Higher potential for fraud or misrepresentation due to minimal regulatory oversight.
  • Difficulty in obtaining reliable information for informed investment decisions.
Due Diligence Checklist:
  • Verify any available financial statements, even if unaudited, for consistency and red flags.
  • Research management's background and track record beyond what is publicly stated.
  • Scrutinize the company's business model and revenue generation for sustainability.
  • Assess the competitive landscape and the company's unique selling propositions.
  • Investigate any news, press releases, or legal filings for potential issues.
  • Understand the specific risks associated with the "OTC Other" tier.
  • Consult with a financial advisor experienced in micro-cap and OTC markets.
Legitimacy Signals:
  • Clearly defined business operations in healthcare services and technology.
  • Established corporate office in Avon, Connecticut.
  • Identified CEO (Paul Cristiano) and employee count (9).
  • Specific offerings in telemedicine, RCM, and preventative care suggest active business.
  • Engagement with diverse client segments including eldercare, municipal, and hospital systems.

Nexteligent Holdings, Inc. Healthcare Stock: Key Questions Answered

What specific challenges does Nexteligent Holdings, Inc. aim to solve for healthcare providers?

Nexteligent Holdings, Inc. addresses several critical challenges faced by modern healthcare providers through its integrated service and technology offerings. Firstly, its Telemedicine Solutions arm tackles the rising costs and operational inefficiencies associated with traditional healthcare delivery by providing virtual care initiatives designed to curb expenses and enhance patient interaction quality. This is particularly relevant for eldercare facilities, municipal bodies, and non-profit organizations seeking to optimize resource allocation. Secondly, the Financial Services segment directly confronts the complexities of healthcare financial administration, offering end-to-end revenue cycle management. A significant pain point for providers is the high volume of denied claims, which Nexteligent specializes in recovering, thereby improving cash flow and financial stability for hospital systems, physician groups, and long-term care providers. Additionally, the company provides ready-to-deploy preventative care solutions, helping providers manage chronic conditions, conduct annual wellness visits, and implement remote patient monitoring, which are crucial for improving patient outcomes and reducing long-term healthcare costs.

How does Nexteligent Holdings, Inc.'s focus on preventative care align with broader healthcare industry trends?

Nexteligent Holdings, Inc.'s emphasis on preventative care solutions, including chronic condition management, annual wellness visits, transitional care management, behavioral health support, and remote patient telemonitoring, aligns directly with a significant and growing trend in the broader healthcare industry: the shift towards value-based care and population health management. Historically, healthcare systems have been largely reactive, focusing on treating illness after it occurs. However, there is an increasing recognition that proactive, preventative measures can significantly improve patient outcomes, reduce the incidence of chronic diseases, and ultimately lower overall healthcare expenditures. By offering ready-to-deploy solutions in these areas, Nexteligent enables healthcare providers to transition towards models that incentivize health maintenance and early intervention. This approach helps providers manage patient populations more effectively, meet quality metrics, and potentially secure better reimbursement rates under value-based payment structures, positioning Nexteligent to capitalize on this fundamental transformation in healthcare delivery.

What are the implications of Nexteligent Holdings, Inc.'s OTC Other listing for potential investors?

Nexteligent Holdings, Inc.'s classification as an "OTC Other" listed entity carries several significant implications for potential investors. This tier represents companies with limited or no public disclosure, meaning there is often a scarcity of reliable, timely financial information, such as audited statements or quarterly reports. This "Unknown" disclosure status makes it challenging to conduct thorough due diligence and accurately assess the company's financial health, operational performance, and strategic direction. Furthermore, OTC Other stocks typically experience very limited market visibility and liquidity. This translates to potentially low trading volumes and wide bid-ask spreads, making it difficult for investors to buy or sell shares efficiently without impacting the price. The lack of stringent regulatory oversight compared to major exchanges also exposes investors to higher risks, including increased stock price volatility and a greater potential for information asymmetry. Investors considering NXGT should be prepared for these challenges and recognize that it operates in a highly speculative segment of the market.

What are the key factors to evaluate for NXGT?

Evaluate NXGT on fundamentals, analyst consensus, and risk factors. Not financial advice.

How frequently does NXGT data refresh on this page?

NXGT prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven NXGT's recent stock price performance?

Nexteligent Holdings, Inc. (NXGT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive suite of integrated healthcare professional services and technology solutions. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider NXGT overvalued or undervalued right now?

Valuing Nexteligent Holdings, Inc. (NXGT) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying NXGT?

Before investing in Nexteligent Holdings, Inc. (NXGT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data is limited to Market Cap, Profit Margin, Beta, and Employee count. No revenue, assets, or detailed income statement/balance sheet information was provided.
  • CEO background and track record details are not available in the source data, leading to 'Unknown' entries.
  • No FMP PEER TICKERS were provided, so the competitors list is empty.
  • The 'Unknown' disclosure status for the OTC listing significantly limits comprehensive analysis.
Data Sources

Popular Stocks